Although direct evidence linking CD44 to TC remains limited, the protein’s well-established functions in other malignancies justify further exploration of its potential role in thyroid tumorigenesis, resistance to therapy, and clinical outcomes. This evidence concerns the gene CD44 and thyroid gland disorder.